APC and neoplasm: In our mouse PDX TNBC model, APC activation in vivo, as monotherapy, was sufficient to stall tumor growth (Figure 4), demonstrating that our in vitro results with human (Figure 1, Figure 2 and Figure 3) and canine [9] cancer cells reflect our in vivo situation.